HALF-YEAR REPORT
April - Juni
2021
Presentation
CEO Håkan Lagerberg
CFO Jenny Graflind
Q2 2021 Highlights
Fast synergies and opening of veterinary clinics gave a record boost in Q2
Strong Growth +400% & organic growth +45%, improved profitability
Strong recovery in Vet & Pet channel
Strong growth in all markets and product groups - Several revenue records in group
New ProDen PlaqueOff® projects and online projects
Largest acquisition in company history -
Vetio
Integration and other Projects
- Launch of Topicals/dermatology products in Pet Retail channel in USA
- Production of dermatology products in Ireland getting closer
- Move of Holden2 warehouse - larger, more effective with other group companies
- Animal Pharm to Amazon and Chewy and Pet MD® on Amazon UK
- Many bigger business opportunities discussed
- Fantastic quarter from many group companies
- Solved Brexit challenges, UK-EU
- Online investments with excellent ROI
Key Performance Indicators
Q2 2021
Key Performance Indicators
H1 2021
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Swedencare AB published this content on 29 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 July 2021 13:18:31 UTC.